L'application de la CPAP precoce chez les nouveau-nes de moins de 34 semaines de gestation diminue le taux d'intubation et la duree de l'oxygenotherapie sans modifier la mortalite et les morbidites. [Early application of CPAP in newborns with gestational age below 34 weeks lowers intubation rate and shortens oxygen therapy without altering mortality and morbidity]

Détails

ID Serval
serval:BIB_D1D366320B9B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
L'application de la CPAP precoce chez les nouveau-nes de moins de 34 semaines de gestation diminue le taux d'intubation et la duree de l'oxygenotherapie sans modifier la mortalite et les morbidites. [Early application of CPAP in newborns with gestational age below 34 weeks lowers intubation rate and shortens oxygen therapy without altering mortality and morbidity]
Périodique
Schweizerische Medizinische Wochenschrift
Auteur(s)
Joris  N., Sudre  P., Moessinger  A.
ISSN
0036-7672 (Print)
Statut éditorial
Publié
Date de publication
12/2000
Volume
130
Numéro
49
Pages
1887-93
Notes
Comparative Study
English Abstract
Journal Article --- Old month value: Dec 9
Résumé
OBJECTIVE: The aim of this study was to test the following hypotheses: the application of early CPAP in the treatment of RDS decreases both the intubation rate and the incidence of bronchopulmonary dysplasia. DESIGN: This retrospective study compares the ventilatory management of premature infants between two periods of 12 months. The first period (July 1996-June 1997) precedes the application of early CPAP, the second (July 1998-June 1999) follows the systematic introduction of early CPAP. POPULATION: All inborn infants, < 34 weeks gestational age and admitted in the Division of Neonatology, CHUV, Lausanne, are included. RESULTS: The intubation rate was reduced significantly from 63.6% in the first period to 23.8% in the second and, if we only consider infants < or = 1500 g, from 72.1 to 30.8% (p < 0.01). The incidence of bronchopulmonary dysplasia, defined as the persistence of oxygen needs at 28 days of life, decreases from 10% in the first period to 4.8% in the second period and, if we only consider infants < or = 1500 g, from 14.7 to 7.7%. These differences are not significant. However we noticed a significant decrease in the duration of O2 therapy from 8.8 days in the first period to 4.6 days in the second (p = 0.04). If we only consider infants < or = 1500 g, the O2 therapy lasted 12.1 days for the first period and 6.8 days for the second. This decrease is not significant. Mortality is identical for both periods: survival rate is 90% in the first period and 90.5% in the second, and 85% and 86.2% respectively if we only consider infants < or = 1500 g. We noticed no significant differences in the morbidity rate (intraventricular haemorrhage, leucomalacia, retinopathy of prematurity and patent ductus arteriosus), except that for infants < or = 1500 g the incidence of pneumothorax was higher in the second period. CONCLUSION: The application of early CPAP significantly reduces the intubation rate without increasing mortality. A decrease in the incidence of bronchopulmonary dysplasia was observed but this finding was not statistically significant.
Mots-clé
Bronchopulmonary Dysplasia/epidemiology/prevention & control Female Gestational Age Humans Infant, Newborn *Infant, Premature Intubation, Intratracheal Male Morbidity *Positive-Pressure Respiration Respiratory Distress Syndrome, Newborn/epidemiology/mortality/*therapy Retrospective Studies Time Factors
Pubmed
Web of science
Création de la notice
25/01/2008 13:16
Dernière modification de la notice
20/08/2019 15:51
Données d'usage